CDTX vs MOS · rev $1.3M vs P/E 161, rev $11.12B
Cidara Therapeutics Inc (CDTX) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
CDTX currently screens at market cap $6.96B. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the CDTX and MOS stock pages for the full models.
Not investment advice.